tiprankstipranks
Trending News
More News >
AuMake Ltd. (AU:AUK)
:AUK
Australian Market
Advertisement

AuMake Ltd. (AUK) AI Stock Analysis

Compare
5 Followers

Top Page

AU:AUK

AuMake Ltd.

(Sydney:AUK)

Select Model
Select Model
Select Model
Underperform 37 (OpenAI - 4o)
Rating:37Underperform
Price Target:
$0.00
▼(-100.00% Downside)
The overall stock score for AuMake Ltd. is primarily driven by its financial performance, which is hindered by persistent losses and negative cash flows despite strong revenue growth. The lack of technical indicators and valuation metrics further limits the ability to assess the stock's market position and attractiveness. Improving profitability and cash flow generation are critical for enhancing the company's financial health and stock performance.

AuMake Ltd. (AUK) vs. iShares MSCI Australia ETF (EWA)

AuMake Ltd. Business Overview & Revenue Model

Company DescriptionAuMake Ltd. (AUK) is an Australian-based company that specializes in the retail and distribution of high-quality Australian products, primarily targeting the Chinese consumer market. The company operates through various sectors, including e-commerce and physical retail, offering a diverse range of products such as health supplements, skincare, and gourmet food items. AuMake aims to bridge the gap between Australian suppliers and Chinese consumers, leveraging its unique market position to provide authentic Australian products to overseas customers.
How the Company Makes MoneyAuMake generates revenue primarily through the sale of Australian products in the Chinese market. Its revenue model includes direct sales through its e-commerce platform, which allows customers to purchase products online, as well as sales made through its physical retail locations. Key revenue streams include product sales, partnerships with Australian suppliers who provide goods for distribution, and potential commission from facilitating transactions for these suppliers. Additionally, AuMake may benefit from strategic partnerships with logistics providers to enhance its supply chain efficiency, thereby reducing costs and increasing profitability.

AuMake Ltd. Financial Statement Overview

Summary
Overall, AuMake Ltd. faces significant financial challenges across all verticals. While the company has shown revenue potential in the past, recent performance indicates substantial declines and operational inefficiencies. The balance sheet reflects increased leverage, and the cash flow statements highlight liquidity constraints, requiring cautious management and strategic repositioning to improve financial health.
Income Statement
35
Negative
AuMake Ltd. has experienced significant volatility in its revenue trajectory, with a notable decline from its 2020 peak. The gross profit margin remains slim, and the company has consistently reported negative net income, leading to a weak net profit margin. The EBIT and EBITDA margins are also negative, indicating challenges in operational efficiency and profitability.
Balance Sheet
40
Negative
AuMake Ltd. shows a concerning debt-to-equity ratio in recent years, as the company has moved from a positive equity position to a more leveraged one. The return on equity is negative, reflecting ongoing net losses. The equity ratio has dropped over time, indicating reduced financial stability and increased reliance on debt.
Cash Flow
30
Negative
The cash flow situation is strained, with negative free cash flow and operating cash flow figures. The company has struggled with generating positive cash flow from operations, impacting its ability to fund capital expenditures and growth. The financing cash flow has been positive, suggesting reliance on external funding to sustain operations.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue39.89M39.77M25.87M2.67M6.01M12.44M
Gross Profit1.09M968.93K843.62K60.17K551.40K1.78M
EBITDA-3.33M-3.39M-5.85M-2.11M-3.56M-19.71M
Net Income-3.42M-3.48M-6.28M-3.03M-6.18M-20.12M
Balance Sheet
Total Assets8.30M8.30M4.37M6.37M10.08M17.34M
Cash, Cash Equivalents and Short-Term Investments1.72M1.72M2.03M1.55M3.04M4.26M
Total Debt1.16M1.16M2.19M0.00520.24K3.06M
Total Liabilities5.64M5.64M3.80M1.26M5.98M11.98M
Stockholders Equity2.55M2.55M524.74K5.11M4.18M5.39M
Cash Flow
Free Cash Flow-4.26M-4.26M-2.84M-3.46M-5.35M-10.48M
Operating Cash Flow-4.26M-4.26M-2.66M-3.46M-4.64M-7.99M
Investing Cash Flow-38.83K-38.83K-318.20K-192.52K589.87K-2.59M
Financing Cash Flow3.93M3.93M3.58M2.00M2.59M6.59M

AuMake Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
AU$82.84M3.7934.61%18.38%6.15%-32.02%
AU$91.74M7.5424.28%13.88%2.76%1.93%
$18.38B12.79-2.54%3.03%1.52%-15.83%
-226.65%53.75%57.58%
-100.00%33.55%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:AUK
AuMake Ltd.
AU:ATP
Atlas Pearls Ltd
0.18
0.06
50.00%
AU:TOY
Toys 'R' Us Anz Limited
0.03
-0.03
-50.00%
AU:STP
Step One Clothing Limited
0.49
-0.90
-64.75%
AU:MHI
Merchant House International Limited
0.15
<0.01
7.14%

AuMake Ltd. Corporate Events

Aumake Partners with Sinomach for Premium Hay Export to China
Oct 23, 2025

Aumake Limited has entered into a non-binding Cooperation Framework Agreement with Sinomach Hainan Development Co., Ltd., a subsidiary of China National Machinery Industry Corporation. This partnership marks Sinomach’s first commercial engagement in Australia and aims to develop a large-scale Premium Hay Supply Chain Project. The project will initially cover 3,000 hectares, with plans to expand to 20,000 hectares, targeting an annual production capacity of 300,000 tonnes. Aumake will manage the Australian operations, while Sinomach will provide technology, infrastructure, and capital support. This collaboration aligns with China’s broader strategy to strengthen international agricultural supply chains and offers Aumake access to Sinomach’s extensive resources and market demand.

Aumake Launches Bio-Basic Under New Incubation Model
Oct 6, 2025

Aumake Limited has launched Bio-Basic Ergothioneine, marking the first brand under its new capital-light incubation model. This strategy aims to develop high-margin health and wellness brands with minimal capital investment, allowing Aumake to retain acquisition rights for successful brands. The launch, supported by a partnership with Mijing Media, combines online and offline distribution channels, enhancing Aumake’s market positioning in China’s premium health market. The initiative demonstrates the viability of Aumake’s model and sets the stage for future brand developments.

AuMake Limited Addresses Late Lodgement of Appendix 3Z
Oct 1, 2025

AuMake Limited announced a late lodgement of Appendix 3Z related to Ms. Hai Yun Chen due to an administrative oversight. The company assured stakeholders that this is an isolated incident and affirmed their commitment to compliance with ASX Listing Rules, indicating no significant impact on their operations or industry positioning.

Aumake Limited Announces Leadership Change and Strategic Focus on High-Margin Growth
Sep 16, 2025

Aumake Limited has announced a leadership transition following the completion of a strategic review, which has provided a roadmap for focusing on high-margin growth opportunities and capital-light distribution models. The resignation of Executive Director Hai Yun Chen is part of the company’s strategy to enhance decision-making and operational focus, with aggressive cost-cutting measures underway to improve cash flow and long-term profitability. This transition marks a significant step in Aumake’s efforts to streamline operations and prioritize margin expansion, positioning the company for sustainable growth and enhanced shareholder value.

AuMake Limited Releases Corporate Governance Statement for FY2025
Sep 11, 2025

AuMake Limited has released its corporate governance statement for the financial year ending June 30, 2025, in compliance with ASX Listing Rules. The statement, available on the company’s website, outlines the extent to which AuMake has adhered to the ASX Corporate Governance Council’s recommendations. This disclosure is crucial for stakeholders as it provides transparency regarding the company’s governance practices and any deviations from recommended practices, which could impact investor confidence and the company’s market positioning.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 19, 2025